| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.54 | 0.005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |